Search

Danny Hong

Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )

Most Active Art Unit
3727
Art Unit(s)
3723, 3727
Total Applications
485
Issued Applications
270
Pending Applications
0
Abandoned Applications
215

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18877402 [patent_doc_number] => 20240000771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => BUPROPION DOSAGE FORMS WITH REDUCED FOOD AND ALCOHOL DOSING EFFECTS [patent_app_type] => utility [patent_app_number] => 18/353323 [patent_app_country] => US [patent_app_date] => 2023-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5610 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18353323 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/353323
Bupropion dosage forms with reduced food and alcohol dosing effects Jul 16, 2023 Issued
Array ( [id] => 19938941 [patent_doc_number] => 12311055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-27 [patent_title] => Compositions and methods for nanoparticle lyophile forms [patent_app_type] => utility [patent_app_number] => 18/346115 [patent_app_country] => US [patent_app_date] => 2023-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8547 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18346115 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/346115
Compositions and methods for nanoparticle lyophile forms Jun 29, 2023 Issued
Array ( [id] => 18877401 [patent_doc_number] => 20240000770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => BUPROPION DOSAGE FORMS WITH REDUCED FOOD AND ALCOHOL DOSING EFFECTS [patent_app_type] => utility [patent_app_number] => 18/333785 [patent_app_country] => US [patent_app_date] => 2023-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5614 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18333785 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/333785
Bupropion dosage forms with reduced food and alcohol dosing effects Jun 12, 2023 Issued
Array ( [id] => 19001913 [patent_doc_number] => 20240065984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT [patent_app_type] => utility [patent_app_number] => 18/208775 [patent_app_country] => US [patent_app_date] => 2023-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43194 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18208775 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/208775
NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT Jun 11, 2023 Abandoned
Array ( [id] => 19472648 [patent_doc_number] => 12102711 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-10-01 [patent_title] => Drug delivery systems and methods for making and using the same [patent_app_type] => utility [patent_app_number] => 18/321173 [patent_app_country] => US [patent_app_date] => 2023-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5888 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18321173 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/321173
Drug delivery systems and methods for making and using the same May 21, 2023 Issued
Array ( [id] => 19584904 [patent_doc_number] => 20240382461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-21 [patent_title] => PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS [patent_app_type] => utility [patent_app_number] => 18/317360 [patent_app_country] => US [patent_app_date] => 2023-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15476 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18317360 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/317360
PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS May 14, 2023 Pending
Array ( [id] => 19134500 [patent_doc_number] => 11969409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Formulations of apremilast [patent_app_type] => utility [patent_app_number] => 18/196718 [patent_app_country] => US [patent_app_date] => 2023-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 22174 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18196718 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/196718
Formulations of apremilast May 11, 2023 Issued
Array ( [id] => 18610739 [patent_doc_number] => 20230277469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => Implantable Device for Sustained Release of a Macromolecular Drug Compound [patent_app_type] => utility [patent_app_number] => 18/315618 [patent_app_country] => US [patent_app_date] => 2023-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18315618 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/315618
Implantable device for sustained release of a macromolecular drug compound May 10, 2023 Issued
Array ( [id] => 18769266 [patent_doc_number] => 20230364022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 18/300739 [patent_app_country] => US [patent_app_date] => 2023-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16088 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18300739 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/300739
Delayed release composition for peroral administration Apr 13, 2023 Issued
Array ( [id] => 18536204 [patent_doc_number] => 20230241292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => BONE VOID FILLER PREPARATION SYSTEM [patent_app_type] => utility [patent_app_number] => 18/134274 [patent_app_country] => US [patent_app_date] => 2023-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7550 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18134274 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/134274
BONE VOID FILLER PREPARATION SYSTEM Apr 12, 2023 Pending
Array ( [id] => 18566108 [patent_doc_number] => 20230256436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS [patent_app_type] => utility [patent_app_number] => 18/296954 [patent_app_country] => US [patent_app_date] => 2023-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10857 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296954 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/296954
Limit size lipid nanoparticles and related methods Apr 5, 2023 Issued
Array ( [id] => 18829554 [patent_doc_number] => 20230398078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-14 [patent_title] => TABLET FOR ORAL SUSPENSION [patent_app_type] => utility [patent_app_number] => 18/191910 [patent_app_country] => US [patent_app_date] => 2023-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8698 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18191910 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/191910
TABLET FOR ORAL SUSPENSION Mar 28, 2023 Abandoned
Array ( [id] => 18522893 [patent_doc_number] => 20230233542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => Methylphenidate Extended Release Chewable Tablet [patent_app_type] => utility [patent_app_number] => 18/184443 [patent_app_country] => US [patent_app_date] => 2023-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15583 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18184443 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/184443
Methylphenidate Extended Release Chewable Tablet Mar 14, 2023 Abandoned
Array ( [id] => 18762983 [patent_doc_number] => 11813363 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-11-14 [patent_title] => Concentrated nutritional or supplemental compound for intestinal, gut-brain axis and neurobiological homeostasis through calibrated absorption including neurotransmitter or any equilibrating compound release to treat or mitigate disease and co-morbidities, particularly obesity and malnourishment [patent_app_type] => utility [patent_app_number] => 18/118919 [patent_app_country] => US [patent_app_date] => 2023-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8057 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18118919 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/118919
Concentrated nutritional or supplemental compound for intestinal, gut-brain axis and neurobiological homeostasis through calibrated absorption including neurotransmitter or any equilibrating compound release to treat or mitigate disease and co-morbidities, particularly obesity and malnourishment Mar 7, 2023 Issued
Array ( [id] => 18610770 [patent_doc_number] => 20230277500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => COMPOSITIONS COMPRISING ATICAPRANT [patent_app_type] => utility [patent_app_number] => 18/179093 [patent_app_country] => US [patent_app_date] => 2023-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58998 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18179093 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/179093
COMPOSITIONS COMPRISING ATICAPRANT Mar 5, 2023 Abandoned
Array ( [id] => 18610961 [patent_doc_number] => 20230277691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => POLYMERS, SYSTEMS, AND METHODS FOR USING AND MONITORING POLYMERS FOR USE IN MEDICAL POLYMERS, IMPLANTS, AND PROCEDURES [patent_app_type] => utility [patent_app_number] => 18/116737 [patent_app_country] => US [patent_app_date] => 2023-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19736 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18116737 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/116737
POLYMERS, SYSTEMS, AND METHODS FOR USING AND MONITORING POLYMERS FOR USE IN MEDICAL POLYMERS, IMPLANTS, AND PROCEDURES Mar 1, 2023 Pending
Array ( [id] => 18836809 [patent_doc_number] => 11844866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-19 [patent_title] => Gastroretentive extended release dosage form [patent_app_type] => utility [patent_app_number] => 18/177348 [patent_app_country] => US [patent_app_date] => 2023-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20631 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18177348 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/177348
Gastroretentive extended release dosage form Mar 1, 2023 Issued
Array ( [id] => 18389725 [patent_doc_number] => 20230157943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => HYDROPHOBIC TOPICAL COMPOSITIONS AND METHODS FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 18/158128 [patent_app_country] => US [patent_app_date] => 2023-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8188 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18158128 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/158128
Hydrophobic topical compositions and methods for producing same Jan 22, 2023 Issued
Array ( [id] => 18544187 [patent_doc_number] => 11717518 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-08-08 [patent_title] => Bupropion dosage forms with reduced food and alcohol dosing effects [patent_app_type] => utility [patent_app_number] => 18/157393 [patent_app_country] => US [patent_app_date] => 2023-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5595 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18157393 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/157393
Bupropion dosage forms with reduced food and alcohol dosing effects Jan 19, 2023 Issued
Array ( [id] => 18842505 [patent_doc_number] => 20230404909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN [patent_app_type] => utility [patent_app_number] => 18/154566 [patent_app_country] => US [patent_app_date] => 2023-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7557 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154566 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/154566
MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN Jan 12, 2023 Abandoned
Menu